A shared platform ends up at the strictest requirement any of its consumers carries, and onboarding is when that gets decided. Vendors fence off the strict part. An internal platform team usually can’t, and the mark only ever moves up.
Last month’s GxP post ended on an open question about agent-written changes swamping per-change assurance. Manufacturing hit that wall a hundred years ago and wrote down its answer, and the answer has an entry fee agent pipelines can’t pay yet.
The agent pitch prices a change by what it costs to produce. A validated GxP system never priced changes that way, and the regulated world already renegotiated the real price once, before agents showed up.
Your audit trail proves the raw record wasn’t tampered with. It says nothing about which definition turned that record into the number you put in a deck, and definitions move.
The whole agent-reliability project is trying to engineer the one thing a tool can’t have: accountability. Data governance already named this. The agent is a custodian, and we keep trying to promote it to owner.
I built audit logs and self-voiding approval gates to make an autonomous agent safe to run unattended, then realized I’d rebuilt a regulation the FDA shipped in 1997. The regulated world solved agent trust before agents existed.
The samples post ended on seating a data steward. This is what you build around that seat in a regulated life sciences org: the roles you actually need, the order to do it in, and why the regulation is the only budget argument that ever works.